本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

157.22
+1.000.64%
盤前156.06-1.1600-0.74%06:54 EDT
成交量:78.55萬
成交額:1.24億
市值:160.36億
市盈率:23.04
高:159.19
開:158.00
低:156.57
收:156.22
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:0.86
換手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.34
市盈率(LYR):33.67

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities